Diabetes mellitus

[@WarmMyth]

Arguably the best lecture on DM I have ever had, thank you very much. Please create more content like this.

[@DrogbaPT454]

Good summary but I highly disagree with your evalution of SGLT2 inhibitors. They are not out of flavor, in fact, they are in very in flavor at the moment. They have show numerous benefits in CKD, HF and MACE outcomes. Sure they do have their drawbacks but are powerful drugs with very good evidence. Also I wouldn't put in the same category DPP4i as Pioglitazone. DPP4i are very safe (except maybe saxagliptin in HF) with few side effects - problem is cost (which I suppose in the US is a bigger issue than in Europe). Pioglitazone is very powerful but cannot be used in HF (which 40-50% of diabetic patients are or have risk factors for - one of them being diabetes itself) and has problems with bone fractures. Still good effort :)

[@alquil5109]

Thank you very much.... You've made DM simple and clear, watching from horn of Africa

[@TheRxCrypto]

PharmD student, here. Love your videos. Really informative. ...Dulaglutide (Trulicity) is not a sulfonylurea, but a GLP-1 Agonist. (It's a, "-tide," like you described above. I'm sure it was a mistake. Just thought it might be necessary for the description. Again, thanks for the vids...they're awesome.

[@krutsaw]

awesome....in a nutshell ❤️ please upload more more such comprehensive clinical videos 🙏 loved it!!

[@Sam_1964]

Excellent lecture

[@weiweizhang7850]

Very good review!!! Thank you!!!

[@zeeshanahmed6210]

Thank you so much ❤️

[@JR-gv4ew]

Thank u Sir